Ondansetron Drug Profile

What is Ondansetron?

Ondansetron is a prescription medication that belongs to a class of drugs called 5-HT3 receptor antagonists, also known as serotonin receptor blockers. It is primarily used to prevent nausea and vomiting caused by chemotherapy, radiation therapy, and surgery. This medication works by blocking specific serotonin receptors in the brain and digestive system that trigger the vomiting reflex.

Uses

Ondansetron has several approved medical uses for preventing and treating nausea and vomiting:

• Chemotherapy-induced nausea and vomiting: Prevents severe nausea and vomiting associated with cancer treatment medications, particularly moderately and highly emetogenic chemotherapy regimens.
• Post-operative nausea and vomiting: Reduces nausea and vomiting that commonly occur after general anesthesia and surgical procedures.
• Radiation therapy-induced nausea: Helps control nausea and vomiting caused by radiation treatment, especially when targeting the abdomen or total body irradiation.
• Hyperemesis gravidarum: Sometimes prescribed off-label for severe pregnancy-related nausea and vomiting when first-line treatments are ineffective.
• Gastroenteritis: May be used in hospital settings to control severe vomiting associated with viral or bacterial stomach infections in children and adults.

How it works

Ondansetron blocks serotonin (5-HT3) receptors located in the chemoreceptor trigger zone of the brain and in the digestive tract. When chemotherapy drugs, anesthesia, or other triggers cause the release of serotonin, these receptors normally signal the brain to initiate vomiting. By blocking these receptors, ondansetron prevents the transmission of nausea and vomiting signals, providing effective symptom control without affecting stomach emptying or bowel motility significantly.

Side effects

Common side effects include:

Submit Your Paper

• Headache
• Constipation
• Drowsiness or fatigue
• Dizziness
• Diarrhea
• Fever
• Injection site reactions (for IV administration)
• Lightheadedness

Serious side effects requiring immediate medical attention:

• Irregular heartbeat or QT prolongation
• Severe allergic reactions including rash, swelling, or difficulty breathing
• Serotonin syndrome (when combined with other serotonin-affecting medications)
• Severe constipation or bowel obstruction
• Fainting or severe dizziness

Warnings and precautions

• Heart rhythm disorders: Patients with existing heart conditions, electrolyte imbalances, or those taking medications that affect heart rhythm should use ondansetron with caution due to risk of QT interval prolongation.
• Pregnancy considerations: Classified as FDA Pregnancy Category B, generally considered safe during pregnancy when benefits outweigh risks, but should only be used when clearly needed and under medical supervision.
• Liver impairment: Patients with severe liver disease may require dose adjustments as ondansetron is metabolized primarily by the liver.
• Phenylketonuria: Some formulations contain aspartame and should be avoided by patients with phenylketonuria (PKU).
• Serotonin syndrome risk: Use caution when combining with other medications that affect serotonin levels, including certain antidepressants and migraine medications.

Interactions

• Apomorphine: Concurrent use can cause profound hypotension and loss of consciousness; combination is contraindicated.
• Tramadol: Ondansetron may reduce tramadol’s analgesic effectiveness by blocking serotonin receptors involved in pain relief.
• QT-prolonging medications: Drugs like certain antibiotics, antiarrhythmics, and antipsychotics may increase risk of dangerous heart rhythm abnormalities.
• Phenytoin and carbamazepine: These seizure medications can increase ondansetron metabolism, potentially reducing its effectiveness.
• Rifampin: This antibiotic can significantly decrease ondansetron blood levels by increasing its breakdown in the liver.
• SSRIs and SNRIs: Antidepressants may increase risk of serotonin syndrome when combined with ondansetron.
• St. John’s Wort: This herbal supplement may reduce ondansetron effectiveness by increasing its metabolism.
• Warfarin: Ondansetron may slightly increase bleeding risk in patients taking this blood thinner.

Check interactions with the GMJ Interaction Checker

Dosage

Typical adult dosages vary depending on the indication and route of administration. For chemotherapy-induced nausea and vomiting, the usual dose is 8 mg taken 30 minutes before chemotherapy, followed by 8 mg every 8 hours for 1-2 days. For post-operative nausea and vomiting prevention, a single 4 mg dose is typically given intravenously before anesthesia induction or orally 1 hour before surgery. Pediatric dosing is weight-based and calculated by healthcare providers. Patients with severe liver impairment may require reduced doses. Always follow your healthcare provider’s specific dosing instructions, as individual requirements may vary based on medical condition, other medications, and treatment response.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).